Duoneb and Ear pain - a phase IV clinical study of FDA data

Summary:

Ear pain is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 50-59 old, also take Singulair, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Ear pain when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Ear pain?

Ear pain is found to be associated with 1,403 drugs and 1,885 conditions by eHealthMe. Check the latest studies of Ear pain.

On Jul, 12, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 31 people (0.39%) have Ear pain.

Among these 31 people:

What is the gender of people who have Ear pain when taking Duoneb? *

female: 70.97 %
male: 29.03 %

What is the age of people who have Ear pain when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Ear pain? *

Stress And Anxiety: 20 people, 64.52%
Weakness: 18 people, 58.06%
Joint Pain: 17 people, 54.84%
Headache (pain in head): 17 people, 54.84%
Dyspnea (difficult or laboured breathing): 16 people, 51.61%
Sinusitis (inflammation of sinus): 16 people, 51.61%
Weight Decreased: 15 people, 48.39%
Fatigue (feeling of tiredness): 14 people, 45.16%
Nausea (feeling of having an urge to vomit): 12 people, 38.71%
Dizziness: 12 people, 38.71%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 16.13%
Light Chain Analysis Increased: 4 people, 12.90%
Metastases To Bone (cancer spreads to bone): 4 people, 12.90%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 9.68%
Stress And Anxiety: 3 people, 9.68%
Back Pain: 2 people, 6.45%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 6.45%
Dyspnea (difficult or laboured breathing): 2 people, 6.45%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 3.23%
Cough: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Ear pain?

- Check whether Ear pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Ear pain treatments and more:

Ear pain (26,025 reports)

How severe was Ear pain and when was it recovered:

Ear pain in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Ear pain and drugs with ingredients of albuterol sulfate; ipratropium bromide (99 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear pain:

Ear pain (1,403 drugs)

Browse all the conditions that are associated with Ear pain:

Ear pain (1,885 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.